Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
Am J Health Syst Pharm. 2006;63(11):1022-1028. Q: How can potential medication errors be minimized when dispensing investigational drugs to better ensure patient safety and improve adherence to ...
The Washington University trial comes as part of a larger platform study, which hopes to understand whether the disease can ...
These programmes are a beacon, offering routes to explore investigational drugs outside the typical confines of clinical trials. 2 They stand as lifelines for those who have journeyed through ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
The University of Chicago will receive up to $130 million in funding over the next 10 years as part of a new drug research ...
AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
Credit: Shutterstock / New Africa. A US university has launched a prevention trial examining the use of Eli Lilly’s investigational remternetug in young adults to prevent further development of ...
Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...
The FDA cleared an investigational new drug application for a phase 1/2 clinical trial to investigate REC-4539 on January 7, 2025. On January 8, 2025, invikafusp alfa (STAR0602) received fast track ...